Rescheduling cannabis to a Schedule 3 drug, if it happens, represents a long-term industry tailwind.

The cannabis company's shares have plummeted by more than 40% over the past year.

Institutions bought this cannabis stock ahead of rescheduling progress, but did they sell on the news?

Organigram Global Inc. (NASDAQ:OGI) is among the Best Marijuana Stocks.

The company isn't in good financial shape, and there's still plenty of risk with the stock.

Cannabis stocks lag in 2026 as hopes of an imminent resheduling of marijuana under the Controlled Substances Act fade. Read more here.

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug. Publicly traded ...

U.S. and Canadian names rally. But one expert notes 'the rescheduling process has faced many hurdles in the past.' Shares of Tilray jumped more than 27% on Tuesday. Shares of U.S. and Canadian ...

While the AI trade was faltering and the broader market was facing increasing selling pressure on Friday, cannabis stocks were performing quite well. Reports that President Donald Trump plans to ...

Aurora Cannabis Inc. reported in line financial results for Q3-2026 with increasing revenue and free cash flow. Learn more ...

Roth Capital Markets analyst Bill Kirk reiterated a “Neutral” rating on ACB and lowered his 12-month price target to C$5.00 ...

President Donald Trump is expected to direct his administration to move to reclassify marijuana as a less dangerous drug, according to people familiar with the matter, a move that could represent one ...